Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA Statement on Trump-Vance Inauguration
HDA released a statement on the inauguration of President Donald J. Trump and Vice President JD Vance.
Three Healthcare Distribution Industry Trends To Watch
For nearly a century, the HDA Factbook has reported on the productivity behind the safe and effective delivery of millions of medicines and healthcare products nationwide. Published by the HDA Research Foundation, the latest Factbook reveals that approximately 95 percent of all pharmaceutical sales moved through the traditional distribution segment in 2023, among other key findings. A recent LinkedIn Live discussion provided additional perspective into the trends shaping the pharmaceutical distribution industry amid an evolving business environment.
HDA Statement on “Most-Favored-Nation” Executive Order
HDA released a statement in response to President Donald J. Trump’s Executive Order establishing a “Most-Favored-Nation” (MFN) pricing policy for pharmaceuticals.
HDA Announces Government Affairs and Policy Staffing Updates
The Healthcare Distribution Alliance (HDA) announces updates regarding staff leading its Government Affairs and Policy teams.